AT375082B - Verfahren zur herstellung von neuen cephalosporinen - Google Patents

Verfahren zur herstellung von neuen cephalosporinen

Info

Publication number
AT375082B
AT375082B AT0410981A AT410981A AT375082B AT 375082 B AT375082 B AT 375082B AT 0410981 A AT0410981 A AT 0410981A AT 410981 A AT410981 A AT 410981A AT 375082 B AT375082 B AT 375082B
Authority
AT
Austria
Prior art keywords
producing new
cephalosporines
new cephalosporines
producing
new
Prior art date
Application number
AT0410981A
Other languages
English (en)
Other versions
ATA410981A (de
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP55132253A external-priority patent/JPS5758689A/ja
Priority claimed from JP55158184A external-priority patent/JPS5782393A/ja
Priority claimed from JP55175263A external-priority patent/JPS6052755B2/ja
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to AT0055683A priority Critical patent/AT378193B/de
Priority to AT0055583A priority patent/AT378962B/de
Priority to AT0055483A priority patent/AT378961B/de
Publication of ATA410981A publication Critical patent/ATA410981A/de
Application granted granted Critical
Publication of AT375082B publication Critical patent/AT375082B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C07D501/56—Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/57—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0410981A 1980-09-25 1981-09-24 Verfahren zur herstellung von neuen cephalosporinen AT375082B (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AT0055683A AT378193B (de) 1980-09-25 1983-02-18 Verfahren zur herstellung von 7-(substituierten oder unsubstituierten amino)-3-(substituierten methyl)-delta3-cephem-4-carbonsaeuren
AT0055583A AT378962B (de) 1980-09-25 1983-02-18 Verfahren zur herstellung von neuen cephalosporinen
AT0055483A AT378961B (de) 1980-09-25 1983-02-18 Verfahren zur herstellung von neuen cephalosporinen

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP55132253A JPS5758689A (en) 1980-09-25 1980-09-25 Novel preparation of 7-substituted or unsubstituted amino-3-substituted methylcephem carboxylic acids
JP55158184A JPS5782393A (en) 1980-11-12 1980-11-12 7-amino-3-(2-(1,2,3,4-tetrazolyl)methyl)cephem-4-carboxylic acid
JP55175263A JPS6052755B2 (ja) 1980-12-13 1980-12-13 新規セファロスポリン類

Publications (2)

Publication Number Publication Date
ATA410981A ATA410981A (de) 1983-11-15
AT375082B true AT375082B (de) 1984-06-25

Family

ID=27316463

Family Applications (4)

Application Number Title Priority Date Filing Date
AT0410981A AT375082B (de) 1980-09-25 1981-09-24 Verfahren zur herstellung von neuen cephalosporinen
AT0055583A AT378962B (de) 1980-09-25 1983-02-18 Verfahren zur herstellung von neuen cephalosporinen
AT0055683A AT378193B (de) 1980-09-25 1983-02-18 Verfahren zur herstellung von 7-(substituierten oder unsubstituierten amino)-3-(substituierten methyl)-delta3-cephem-4-carbonsaeuren
AT0055483A AT378961B (de) 1980-09-25 1983-02-18 Verfahren zur herstellung von neuen cephalosporinen

Family Applications After (3)

Application Number Title Priority Date Filing Date
AT0055583A AT378962B (de) 1980-09-25 1983-02-18 Verfahren zur herstellung von neuen cephalosporinen
AT0055683A AT378193B (de) 1980-09-25 1983-02-18 Verfahren zur herstellung von 7-(substituierten oder unsubstituierten amino)-3-(substituierten methyl)-delta3-cephem-4-carbonsaeuren
AT0055483A AT378961B (de) 1980-09-25 1983-02-18 Verfahren zur herstellung von neuen cephalosporinen

Country Status (27)

Country Link
US (4) US4489072A (de)
KR (1) KR860000932B1 (de)
AR (1) AR240645A1 (de)
AT (4) AT375082B (de)
AU (3) AU550330B2 (de)
CA (2) CA1204735A (de)
CH (4) CH652129A5 (de)
DD (2) DD208351A5 (de)
DE (5) DE3152935C2 (de)
DK (1) DK163877C (de)
EG (1) EG17373A (de)
ES (4) ES505760A0 (de)
FI (2) FI75575C (de)
FR (2) FR2509310B1 (de)
GB (3) GB2089339B (de)
HU (1) HU185850B (de)
IN (4) IN155375B (de)
IT (1) IT1172201B (de)
LU (1) LU83650A1 (de)
MX (1) MX155025A (de)
NL (1) NL8104386A (de)
NO (1) NO161117C (de)
NZ (1) NZ198350A (de)
PH (5) PH18072A (de)
PT (1) PT73727B (de)
RO (4) RO86824B (de)
SE (5) SE453090B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703046A (en) * 1978-09-08 1987-10-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds and processes for preparation thereof
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
EP0061234A3 (de) * 1981-03-05 1983-11-16 Beecham Group Plc Cephalosporin derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
EP0081971A3 (de) * 1981-12-08 1984-09-26 Tanabe Seiyaku Co., Ltd. Cephalosporinderivate und Verfahren zu ihrer Herstellung
US4618606A (en) * 1982-11-17 1986-10-21 Toyama Chemical Co., Ltd. Antibiotic 7-(thiazolyl)-3-(pyrazinylmethyl) or (pyridazinylmethyl) cephalosporins
DK521883A (da) * 1982-11-17 1984-05-18 Toyama Chemical Co Ltd Cephalosporinderivater, fremgangsmaade til fremstilling heraf og fremgangsmaade til fremstilling af mellemprodukter herfor
JPS6064986A (ja) * 1983-09-20 1985-04-13 Toyama Chem Co Ltd セファロスポリン類の製造法
JPS60190783A (ja) * 1983-12-21 1985-09-28 Sumitomo Seiyaku Kk セフエム系化合物
GB8406231D0 (en) * 1984-03-09 1984-04-11 Fujisawa Pharmaceutical Co Cephem compounds
AT397086B (de) * 1984-05-25 1994-01-25 Toyama Chemical Co Ltd Verfahren zur herstellung von neuen 2-(2-aminothiazol-4-4yl)-2-(syn)-alkoxyimino- acetamiden
GB2161476B (en) * 1984-05-25 1988-01-27 Toyama Chemical Co Ltd 2-aminothiazolyl-2-methoxyimino acetamides and their use in preparing cephalosporins
FI851934L (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporinderivat.
DE3539901A1 (de) * 1985-11-11 1987-05-14 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
JPH064643B2 (ja) * 1985-12-20 1994-01-19 ファイザー製薬株式会社 セフアロスポリン化合物
US4692517A (en) * 1986-03-20 1987-09-08 American Home Products Corporation C-3' acylaminooxy-7-[(2-aminothiazol-4-yl)-α-(substituted-oximino)acetyl]cephalosporin derivatives
EP0265185A3 (de) * 1986-10-21 1990-03-28 Beecham Group Plc Cephalosporine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
ZA877987B (en) * 1986-11-12 1988-08-31 Ici Pharma Antibiotic compounds
EP0269298B1 (de) * 1986-11-21 1994-10-19 Ici Pharma Cephalosporine, Verfahren zu ihrer Herstellung und pharmazeutische Präparate
ATE113050T1 (de) * 1986-11-21 1994-11-15 Ici Pharma Cephalosporine, verfahren zu ihrer herstellung und pharmazeutische präparate.
US4847373A (en) * 1987-02-26 1989-07-11 Bristol-Myers Company Production of 3-allyl- and 3-butenyl-3-cephems
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
US5232918A (en) * 1987-07-23 1993-08-03 Imperial Chemical Industries Plc Cephalosporin derivatives
GB8811056D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
JPH0699443B2 (ja) * 1989-09-29 1994-12-07 ファイザー製薬株式会社 セファロスポリン化合物
US6800756B2 (en) * 2002-05-03 2004-10-05 Orchid Chemicals And Pharmaceuticals, Ltd. Method for the preparation of ceftiofur sodium and its intermediates
ES2348299T3 (es) * 2003-04-16 2010-12-02 Sandoz Ag Procedimientos para la preparación de cefepime.
US7847093B2 (en) * 2003-04-16 2010-12-07 Sandoz Ag Processes for the preparations of cefepime
US20050288347A1 (en) * 2004-03-26 2005-12-29 Hodge Carl N Certain triazole-based compounds, compositions, and uses thereof
US8198434B2 (en) * 2008-05-07 2012-06-12 Idexx Laboratories, Inc. Process for preparing cefsulodin sodium
CA2828114A1 (en) * 2010-02-26 2011-09-01 Gary Igor DMITRIENKO Cephalosporin derivatives useful as .beta.-lactamase inhibitors and compositions and methods of use thereof
CN102351886B (zh) * 2011-09-07 2013-10-16 山东罗欣药业股份有限公司 头孢特仑新戊酯晶体、其制备方法及含有该晶体的组合物片剂
AU2014291142B2 (en) 2013-07-17 2018-10-11 Otsuka Pharmaceutical Co., Ltd. Cyanotriazole compounds
CN106046026B (zh) * 2016-06-30 2018-07-06 济南康和医药科技有限公司 一种头孢特仑新戊酯的制备方法
CN112645842B (zh) * 2020-12-25 2022-08-19 复旦大学 一种氰乙酸叔丁酯的连续流制备方法

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB912541A (en) * 1958-03-17 1962-12-12 Nat Res Dev Cephalosporin c compounds
DE1795484U (de) 1959-04-21 1959-09-10 Richard Langer Quertraeger fuer laengsdraehte zum abstuetzen von pflanzen, insbesondere weinreben.
GB1032641A (en) 1962-02-16 1966-06-15 Edward Penley Abraham Cephalosporins
GB1057883A (en) * 1962-07-11 1967-02-08 Glaxo Lab Ltd Improvements in or relating to antibiotics
US3226384A (en) 1963-01-25 1965-12-28 Nat Res Dev Cephalosporin ca derivatives
BE634644A (de) * 1963-07-10
US3821206A (en) * 1966-12-15 1974-06-28 Glaxo Lab Ltd Cephalosporins having a polyazole substituent
GB1211694A (en) * 1966-12-15 1970-11-11 Glaxo Lab Ltd Derivatives of 7-aminocephalosporanic acid
GB1360860A (en) * 1970-07-08 1974-07-24 Ciba Geigy Ag Cepham compounds process for their manufacture and compositions containing them
US3932465A (en) * 1970-07-08 1976-01-13 Ciba-Geigy Corporation 3-R-methyl-7-amino-ceph-em-4-carboxylic acid compounds
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
US4343937A (en) * 1971-06-02 1982-08-10 Merck & Co., Inc. 3-Substituted-7-methoxy-7-amino-3-cephem-4-carboxylic acids
SU589918A3 (ru) * 1971-07-14 1978-01-25 Мерк Энд Ко Инк (Фирма) Способ получени сложного эфира 3-замещенной метил-7-ациломидо-7-метокси-2-цефем -4- карбоноаой кислоты
JPS5653557B2 (de) * 1973-10-15 1981-12-19
CH605997A5 (de) * 1974-08-30 1978-10-13 Ciba Geigy Ag
DK43476A (da) * 1975-02-04 1976-08-05 Fujisawa Pharmaceutical Co Fremgangsmade til fremstilling af cephemcarboxylsyrer
GB1547165A (en) * 1975-08-15 1979-06-06 Beecham Group Ltd 3-carbamoylbenzyl and 3-(carbamoylpyridylmethyl)-cephems
GB1575803A (en) * 1976-03-09 1980-10-01 Fujisawa Pharmaceutical Co 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof
US4165430A (en) * 1976-03-19 1979-08-21 Glaxo Laboratories Limited Cephalosporins having a 7-carboxy substituted α-etherified oximinoarylacetamido) group
JPS5946237B2 (ja) * 1976-04-02 1984-11-10 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
DE2760484C2 (de) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
GB1565941A (en) 1977-02-08 1980-04-23 Toyama Chemical Co Ltd Process for producing 7-(substituted)amino-3-substituted thiomethyl cephem carboxylic acids
ES467601A1 (es) * 1977-03-12 1979-06-16 Hoechst Ag Procedimiento para la preparacion de derivados de cefem.
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
DE2822861A1 (de) * 1978-05-26 1979-11-29 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
JPS6027677B2 (ja) 1978-07-06 1985-06-29 富山化学工業株式会社 ７−置換又は非置換アミノ−３−置換チオメチルセフエムカルボン酸類の新規製造法
ES485440A1 (es) * 1978-10-27 1980-07-01 Glaxo Group Ltd Un procedimiento para la preparacion de antibioticos de ce- falosporina
DE2946038A1 (de) * 1978-11-15 1980-05-29 Glaxo Group Ltd Cephalosporinantibiotika
FR2449692A1 (fr) 1979-02-23 1980-09-19 Glaxo Group Ltd Nouvelles cephalosporines qui exercent une activite contre les organismes gram-negatifs
JPS55139387A (en) 1979-04-19 1980-10-31 Yamanouchi Pharmaceut Co Ltd Novel synthetic method of 7-amino-3-heterocyclic thiomethyl-delta3-carboxylic acids
JPS55153790A (en) 1979-05-17 1980-11-29 Yamanouchi Pharmaceut Co Ltd Preparation of 7-amino-3-heterocyclic thiomethyl-delta3- cephem-4-carboxylic acid
FR2461713A1 (fr) * 1979-07-19 1981-02-06 Roussel Uclaf Nouvelles alcoyloximes substituees derivees de l'acide 7-(2-amino 4-thiazolyl) acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
NZ198350A (en) * 1980-09-25 1985-02-28 Toyama Chemical Co Ltd Cephalosporins and intermediates;pharmaceutical compositions
EP0061234A3 (de) * 1981-03-05 1983-11-16 Beecham Group Plc Cephalosporin derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
EP0135683B1 (de) * 1981-09-10 1987-07-22 Takeda Chemical Industries, Ltd. Dioxaphosphole in der Herstellung von Cephalosporinderivaten
JPS6064986A (ja) * 1983-09-20 1985-04-13 Toyama Chem Co Ltd セファロスポリン類の製造法
GB2161476B (en) * 1984-05-25 1988-01-27 Toyama Chemical Co Ltd 2-aminothiazolyl-2-methoxyimino acetamides and their use in preparing cephalosporins
CA1293719C (en) * 1986-09-22 1991-12-31 Takao Takaya Cephem compounds and processes for preparation thereof

Also Published As

Publication number Publication date
FR2511377A1 (fr) 1983-02-18
GB2135304B (en) 1985-03-27
IN159126B (de) 1987-03-28
IN158589B (de) 1986-12-13
ATA410981A (de) 1983-11-15
NO161117B (no) 1989-03-28
ES8301998A1 (es) 1983-01-01
AT378961B (de) 1985-10-25
HU185850B (en) 1985-04-28
PH18484A (en) 1985-08-02
IT1172201B (it) 1987-06-18
CH652129A5 (de) 1985-10-31
ES514669A0 (es) 1983-05-01
AR240645A1 (es) 1990-07-31
SE453090B (sv) 1988-01-11
PH18072A (en) 1985-03-18
SE8600195L (sv) 1986-01-16
ATA55483A (de) 1985-03-15
SE8600194D0 (sv) 1986-01-16
PH20221A (en) 1986-10-23
DE3137854C2 (de) 1987-06-19
SE468478B (sv) 1993-01-25
ATA55683A (de) 1984-11-15
SE8600192L (sv) 1986-01-16
DK163877B (da) 1992-04-13
FR2509310B1 (fr) 1985-08-02
LU83650A1 (fr) 1982-01-21
AU550330B2 (en) 1986-03-20
DE3152932C2 (de) 1990-02-08
CA1200541A (en) 1986-02-11
EG17373A (en) 1990-12-30
DE3152931C2 (de) 1989-10-05
RO86825A (ro) 1985-05-20
SE468479B (sv) 1993-01-25
IN155375B (de) 1985-01-19
SE8600194L (sv) 1986-01-16
MX155025A (es) 1988-01-20
SE468477B (sv) 1993-01-25
DE3137854A1 (de) 1982-04-15
FI75575C (fi) 1988-07-11
FI75575B (fi) 1988-03-31
RO86823A (ro) 1985-05-20
AT378962B (de) 1985-10-25
DE3152934C2 (de) 1990-01-18
CH652130A5 (de) 1985-10-31
CA1204735A (en) 1986-05-20
US4879381A (en) 1989-11-07
SE8600195D0 (sv) 1986-01-16
RO86824B (ro) 1985-05-31
FI80041C (fi) 1990-04-10
SE8600192D0 (sv) 1986-01-16
SE8600193L (sv) 1986-01-16
DE3152935C2 (de) 1992-07-16
US4489072A (en) 1984-12-18
US4673738A (en) 1987-06-16
CH651837A5 (de) 1985-10-15
DK163877C (da) 1992-09-14
ATA55583A (de) 1985-03-15
FR2509310A1 (fr) 1983-01-14
ES505760A0 (es) 1983-01-01
US5144027A (en) 1992-09-01
FR2511377B1 (fr) 1985-12-13
AT378193B (de) 1985-06-25
SE468476B (sv) 1993-01-25
SE8600193D0 (sv) 1986-01-16
CH652128A5 (de) 1985-10-31
NZ198350A (en) 1985-02-28
GB2089339A (en) 1982-06-23
KR860000932B1 (ko) 1986-07-19
DD202436A5 (de) 1983-09-14
ES514671A0 (es) 1983-05-01
ES8306157A1 (es) 1983-05-01
GB8402250D0 (en) 1984-02-29
DD208351A5 (de) 1984-05-02
DK421881A (da) 1982-04-15
ES8306155A1 (es) 1983-05-01
PT73727B (en) 1982-12-30
GB2089339B (en) 1985-04-24
ES8306156A1 (es) 1983-05-01
ES514670A0 (es) 1983-05-01
RO82689A (ro) 1983-11-01
PH19251A (en) 1986-02-17
NO161117C (no) 1989-07-05
FI870153A0 (fi) 1987-01-15
GB2135304A (en) 1984-08-30
IT8149348A0 (it) 1981-09-23
FI812980L (fi) 1982-03-26
AU4986185A (en) 1986-03-20
GB8402249D0 (en) 1984-02-29
RO86825B (ro) 1985-05-31
RO86824A (ro) 1985-05-20
FI80041B (fi) 1989-12-29
PT73727A (en) 1981-10-01
NO813252L (no) 1982-03-26
SE8105658L (sv) 1982-05-05
NL8104386A (nl) 1982-04-16
GB2136420A (en) 1984-09-19
IN158590B (de) 1986-12-13
AU7543881A (en) 1982-04-01
FI870153A (fi) 1987-01-15
RO82689B (ro) 1983-10-30
PH19147A (en) 1986-01-15
RO86823B (ro) 1985-05-31
AU568033B2 (en) 1987-12-10
AU4986285A (en) 1986-04-24
AU558649B2 (en) 1987-02-05
GB2136420B (en) 1985-05-01

Similar Documents

Publication Publication Date Title
AT378961B (de) Verfahren zur herstellung von neuen cephalosporinen
AT378768B (de) Verfahren zur herstellung von neuen 1-sulfo-2-oxoazetidin-derivaten
AT377524B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT382612B (de) Verfahren zur herstellung von neuen arylcyclobutylalkylaminen
AT384017B (de) Verfahren zur herstellung von neuen hydroxyaminoestern
ATA125383A (de) Verfahren zur herstellung von neuen benzoazacycloalkyl-spiro-imidazolidinen
ATA206483A (de) Verfahren zur herstellung von neuen mitosanderivaten
AT382638B (de) Verfahren zur herstellung von neuen trehaloselipiden
AT376654B (de) Verfahren zur herstellung von neuen 1-phenyl-2cyclohexen-1-alkylamin-derivaten
AT386199B (de) Verfahren zur herstellung von neuen 2-piperazinopyrimidinen
AT380683B (de) Verfahren zur herstellung von neuen diaminophenolaethern
AT379388B (de) Verfahren zur herstellung von neuen 4-chinolonderivaten
AT376679B (de) Verfahren zur herstellung von neuen bisindolalkaloiden
AT375076B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT384214B (de) Verfahren zur herstellung von neuen mercaptoacylcarnitinen
AT373231B (de) Verfahren zur herstellung von neuen alkoxyalkanoyl-carnitinhydrohalogeniden
AT373891B (de) Verfahren zur herstellung von neuen rifamycinderivaten
AT374451B (de) Verfahren zur herstellung von neuen benzylidenderivaten
AT381940B (de) Verfahren zur herstellung von neuen ergolinderivaten
AT381939B (de) Verfahren zur herstellung von neuen azaspiroalkandionen
ATA354581A (de) Verfahren zur herstellung von neuen 11-hydroxy-13 -oxa-postaglandinderivaten
AT378776B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
ATA67481A (de) Verfahren zur herstellung von neuen androstancarbothioaten
ATA34491A (de) Verfahren zur herstellung von neuen androstancarbothioaten
ATA17084A (de) Verfahren zur herstellung von neuen androstancarbothioaten

Legal Events

Date Code Title Description
ELA Expired due to lapse of time
EIH Change in the person of patent owner
ELJ Ceased due to non-payment of the annual fee